SCHEMBL163296

SCHEMBL163296

OC(OCc1cccc2ccccc12)c1cccc2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.51
SLC1A2 P43004 1/20 0.51
SLC1A1 P43005 1/20 0.51
PARP10 Q53GL7 1/20 0.46
CYP1A2 P05177 3/20 0.43
CYP2C19 P33261 3/20 0.43
CYP2C9 P11712 2/20 0.43
ALDH1A1 P00352 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
ACP3 P15309 1/20 0.41
PSMB5 P28074 1/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
ATM Q13315 1/20 0.40
FFAR1 O14842 1/20 0.40
AKR1B1 P15121 1/20 0.40
CTNNB1 P35222 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1567092 0.80 PNMT (0.43) SLC1A3SLC1A2SLC1A1PARP10CYP1A2
SCHEMBL15751163 0.79 TSHR (0.47) CYP1A2CYP2C19CYP2C9ALDH1A1KMT2A
SCHEMBL9035787 0.78 CASR (0.48) SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19
SCHEMBL10819592 0.75 SLC1A3 (0.53) SLC1A3SLC1A2SLC1A1PARP10CYP1A2
SCHEMBL31432573 0.75 SLC1A3 (0.53) SLC1A3SLC1A2SLC1A1PARP10CYP1A2
SCHEMBL16247743 0.73 SLC1A3 (0.48) SLC1A3SLC1A2SLC1A1PARP10CYP1A2
SCHEMBL24372107 0.73 CYP1A2 (0.50) CYP1A2CYP2C19CYP2C9ALDH1A1MEN1
SCHEMBL5608955 0.73 ALDH1A1 (0.50) CYP1A2CYP2C19CYP2C9ALDH1A1MEN1
SCHEMBL14443332 0.72 SLC1A3 (0.50) SLC1A3SLC1A2SLC1A1PARP10CYP1A2
SCHEMBL28480565 0.72 MEN1 (0.54) SLC1A3SLC1A2SLC1A1PARP10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611805-A1 FUSED TRIAZOLES FOR THE TREATMENT OR PROPHYLAXIS OF MILD COGNITIVE IMPAIRMENT Takeda Pharmaceutical Company Limited (JP) 2013-07-10 EP disclosed
WO-2012029991-A1 FUSED TRIAZOLES FOR THE TREATMENT OR PROPHYLAXIS OF MILD COGNITIVE IMPAIRMENT TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-08 WO disclosed